A comparative study of rasagiline versus placebo or entacapone as adjunt to levodopa in Parkinson's disease (PD) patients with motor fluctuations (the LARGO Study).

O. Rascol, D. J. Brooks, E. Melamed, W. H. Oertel, W. Poewe, F. Stocchi, E. Tolosa, Carl Edward Counsell, LARGO Study Group

Research output: Contribution to journalArticle

32 Citations (Scopus)
Original languageEnglish
Pages (from-to)S200-S201
JournalMovement Disorders
Volume19
Issue numberSUPPL 9
Publication statusPublished - 2004

Cite this

Rascol, O., Brooks, D. J., Melamed, E., Oertel, W. H., Poewe, W., Stocchi, F., Tolosa, E., Counsell, C. E., & LARGO Study Group (2004). A comparative study of rasagiline versus placebo or entacapone as adjunt to levodopa in Parkinson's disease (PD) patients with motor fluctuations (the LARGO Study). Movement Disorders, 19(SUPPL 9), S200-S201.